Sunesis Pharmaceuticals (FRA:RYIS) Receivables Turnover : 0.00 (As of Dec. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Sunesis Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sunesis Pharmaceuticals's Revenue for the three months ended in Dec. 2020 was €0.00 Mil. Sunesis Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2020 was €0.00 Mil.

Sunesis Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Sunesis Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunesis Pharmaceuticals Receivables Turnover Chart

Sunesis Pharmaceuticals Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Receivables Turnover

Get a 7-Day Free Trial

Sunesis Pharmaceuticals Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sunesis Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Sunesis Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunesis Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunesis Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Sunesis Pharmaceuticals's Receivables Turnover falls into.

Sunesis Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Sunesis Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2020 is calculated as

	Receivables Turnover (A: Dec. 2020 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2020 )	/ (	(Accounts Receivable (A: Dec. 2019 )	+	Accounts Receivable (A: Dec. 2020 ))	/	count )
=	0.099	/ (	(0	+	0)	/	1 )
=	0.099	/	0
=	N/A

Sunesis Pharmaceuticals's Receivables Turnover for the quarter that ended in Dec. 2020 is calculated as

	Receivables Turnover (Q: Dec. 2020 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2020 )	/ (	(Accounts Receivable (Q: Sep. 2020 )	+	Accounts Receivable (Q: Dec. 2020 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Sunesis Pharmaceuticals (FRA:RYIS) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Sunesis Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Sunesis Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunesis Pharmaceuticals (FRA:RYIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunesis Pharmaceuticals Inc (FRA:RYIS) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

395 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

http://www.sunesis.com

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.

Sunesis Pharmaceuticals (FRA:RYIS) Headlines

No Headlines